A Phase I Study Of Myo-inositol For Lung Cancer Chemoprevention
| 効果 | 減少 |
| 試験方法 | コホート法 |
| 試験期間 | 1-6 ヶ月 |
| 被験者数 | 10 |
| 性別 | 男女 |
| 年齢 | 45-64, 65+ |
| 体型 | 肥満 |
この研究の注釈：
In smokers with bronchial dysplasia (the progression of this dysplasia being used as an indicator for cancer risk), the rates of regression were increased from 48% to 91% when _Myo_-inositol was supplemented at 18g daily for a period of three months.